A new study conducted by researchers in Malaysia reveals that EVNol™ – full spectrum palm tocotrienol-tocopherol complex confers neuroprotection by reducing expression of CD40 (ie: co-stimulatory molecule produced by microglia). Increased in the expression of CD40 is associated with the development of neurodegenerative diseases.

In this study, the BV2 or microglial cells (ie: central nervous system-specific macrophages) are divided into unstimulated and LPS (lipopolysaccharide)-stimulated groups. Both groups are treated with EVNol™ 50% (full spectrum palm tocotrienol-tocopherol complex, formerly known as Tocomin® 50%, supplied by ExcelVite) and delta-tocotrienol and followed by addition of LPS in the LPS- stimulated group. A chemical scavenging assay was conducted to study the nitrite scavenging activity of delta-tocotrienol. The examination of the effects of EVNol™50% and delta-tocotrienol on the expression of CD40 on microglial cells by flow cytometry was also carried out.

The results indicate that both EVNol™50% and delta-tocotrienol exert anti-inflammatory effects by reducing expression of CD40. Additionally, EVNol™ 50% shows significant reduced CD40 expression per microglial cell whereas delta-tocotrienol demonstrate statistically insignificant reduction. It is also shown that delta-tocotrienol does not inhibit NO (nitrite oxide) production of microglia via nitrate scavenging.

“This is the first study to demonstrate that palm tocotrienol-tocopherol complex but not delta-tocotrienol decreases the expression of CD40 per microglial cell effectively, suggesting that the synergistic effects of full spectrum tocotrienol/tocopherol complex conferring stronger protective effects on brain health, when compared to delta-tocotrienol alone. The reduction of the expression of CD40 is also correlated with reduced risks of neurodegenerative diseases such as Alzheimer’s disease, Parkinson disease and other brain-related injuries,” said CheeYen Lau, Nutritionist of ExcelVite.

“This new finding complements to the current NIH-Funded Studies at the Ohio State University, Wexner Medical Center on EVNol™ and EVNol SupraBio™ -full spectrum palm tocotrienol complex in brain protection as well as a recent large published human clinical study on EVNol SupraBio™ in White Matter Lesions (2-6). We are delighted to see the increasing interest from researchers in studying neuroprotective properties of EVNol™ and EVNol SupraBio™ and look forward to seeing more results, particularly human studies in the future,” added Lau.

Sources:
1. Tan S. W., et.al (2016).Palm Tocotrienols Reduce Lipopolysaccharide-Stimulated Inflammatory Responses of Microglia. Malaysian Journal of Medicine and Health Sciences; 12:2.
2. Sen CK, et al. (2000). Molecular Basis of Vitamin E Action: Tocotrienol potently inhibits glutamate-induced pp60c-Src kinase and death of HT4 neuronal cells. The Journal of Biological Chemistry, 275 (17), 13049-13055.
3. Khanna S, et al. (2003). Molecular Basis of Vitamin E Action: Tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration. The Journal of Biological Chemistry, 278 (44), 43508-43515.
4. Khanna S, et al. (2005). Neuroprotective Properties of the Natural Vitamin E alpha-Tocotrienol. Stroke, 36, e144-e152.
5. Khanna S, et al. (2010). Nanomolar vitamin E alpha-tocotrienol inhibits glutamate-induced activation of phospholipase A2 and causes neuroprotection. Journal of Neurochemicstry, 112, 1248-1260.
6. Khanna S, et.al (2013). Loss of miR-29b following acute ischemic stroke contributes to neural cell death and infarct size. Journal of Cerebral Blood Flow & Metabolism, 33:1197-1206.

Disclaimer: The statements in the above article have not been evaluated by the Food and Drug Administration. They are not intended to diagnose, treat, cure or prevent any disease.

mersin duvar kağıdı web tasarım Premium Hosting web hosting